Quiz 3 Flashcards
PK genes
CYP... 2D6 2C19 1A2 2B6 3A4
PD genes
SLC 6A4 (serotonin transporter)
5HTR2A (serotonin 2A receptor)
HLA-B 1502
HLA-A 3101
Ultra-rapid
Increased expression of metabolizing enzyme, likely low therapeutic levels since metabolizes quickly
Extensive
Normal phenotype
Intermediate
Reduced enzyme activity. Will metabolize a drug, but at a reduced rate.
Poor
Decreased or no expression of a metabolizing enzyme. Will metabolize a drug very slowly or not at all
Positive symptoms associated with which brain region?
mesolimbic/nucleus accumbens (reward circuitry/motivation)
Negative symptoms associated with which brain region?
mesocortical/prefrontal cortex; may also involve mesolimbic regions such as nucleus accumbens
Aggressive symptoms associated with which brain region?
orbitofrontal cortex; amygdala
Affective symptoms associated with which brain region?
ventromedial prefrontal cortex
Cognitive symptoms associated with which brain region?
dorsolateral prefrontal cortex
memantine MOA
NMDA antagonist-
blocks the toxic effects associated with excess glutamate, regulates glutamate activation
Donepezil MOA
(Cholestinerase inhibitor)
Prevents break down of acetylcholine in the brain
Rivastigmine MOA
(Cholestinerase inhibitor)
Prevents break down of acetylcholine and butyrylcholine in the brain
Galantamine MOA
(Cholestinerase inhibitor)
Prevents break down of acetylcholine in the brain and stimulates nicotinic receptors to release more acetylcholine in the brain